Study designs of evaluations included in the review
Controlled clinical trials with at least two patients per treatment group were eligible for inclusion.
Specific interventions included in the review
Studies of biofeedback, acupuncture and TENS were eligible, and were included in the review. The studies could use these interventions alone, or in conjunction with a management programme if the control group also received the management programme.
Participants included in the review
Studies of patients with signs and symptoms of TMD according to the Research Diagnostic Criteria for TMD and/or the International Headache Society classification systems were eligible for inclusion. Studies that did not define TMD in the text or using a reference were excluded.
Outcomes assessed in the review
Studies that assessed pain, subjective improvement of symptoms or functional status were eligible for inclusion. The included studies assessed the outcomes using a variety of measure (details were reported).
How were decisions on the relevance of primary studies made?
The authors did not state how the papers were selected for the review, or how many reviewers performed the selection.